Rtw Investments, LP Acadia Pharmaceuticals Inc Transaction History
Rtw Investments, LP
- $6.23 Billion
- Q1 2024
A detailed history of Rtw Investments, LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Rtw Investments, LP holds 13,829,315 shares of ACAD stock, worth $216 Million. This represents 4.1% of its overall portfolio holdings.
Number of Shares
13,829,315
Previous 11,253,551
22.89%
Holding current value
$216 Million
Previous $352 Million
27.43%
% of portfolio
4.1%
Previous 5.78%
Shares
7 transactions
Others Institutions Holding ACAD
# of Institutions
299Shares Held
158MCall Options Held
1.88MPut Options Held
688K-
Baker Bros. Advisors LP New York, NY42.9MShares$669 Million10.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$207 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$182 Million0.01% of portfolio
-
State Street Corp Boston, MA6MShares$93.6 Million0.01% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.99MShares$93.5 Million3.16% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.52B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...